CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: Assessment of LBR-101 In Chronic Migraine [Phase 2]

Phase 2 clinical trial assessing LBR-101 in chronic migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Chronic Migraine | Phase 2 | Status: COMPLETED | Results posted: 2021-11-01